SCHEMBL9664667

SCHEMBL9664667

O=C(Cl)CCCCCCCCc1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.71
RXFP1 Q9HBX9 1/20 0.71
HDAC1 Q13547 5/20 0.62
HDAC2 Q92769 3/20 0.62
ALOX5 P09917 3/20 0.62
FAAH O00519 3/20 0.61
CES1 P23141 3/20 0.61
HDAC3 O15379 2/20 0.59
HDAC4 P56524 2/20 0.59
HDAC7 Q8WUI4 2/20 0.59
HDAC10 Q969S8 2/20 0.59
HDAC11 Q96DB2 2/20 0.59
HDAC8 Q9BY41 2/20 0.59
HDAC6 Q9UBN7 2/20 0.59
HDAC9 Q9UKV0 2/20 0.59
HDAC5 Q9UQL6 2/20 0.59
MAPK1 P28482 1/20 0.59
ADRA1A P35348 1/20 0.59
SLC6A3 Q01959 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3253249 1.00 MAPT (0.71) MAPTRXFP1HDAC1HDAC2ALOX5
SCHEMBL3250759 1.00 MAPT (0.71) MAPTRXFP1HDAC1HDAC2ALOX5
SCHEMBL7768077 1.00 MAPT (0.71) MAPTRXFP1HDAC1HDAC2ALOX5
SCHEMBL7883758 1.00 MAPT (0.71) MAPTRXFP1HDAC1HDAC2ALOX5
SCHEMBL5793035 1.00 MAPT (0.71) MAPTRXFP1HDAC1HDAC2ALOX5
SCHEMBL9664005 1.00 MAPT (0.71) MAPTRXFP1HDAC1HDAC2ALOX5
SCHEMBL384438 0.98 MAPT (0.68) MAPTRXFP1HDAC1HDAC2ALOX5
SCHEMBL8772423 0.94 MAPT (0.82) MAPTRXFP1HDAC1HDAC2ALOX5
SCHEMBL61491 0.92 HDAC1 (0.69) MAPTRXFP1HDAC1HDAC2ALOX5
SCHEMBL27538484 0.90 HDAC1 (0.67) MAPTRXFP1HDAC1HDAC2ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0273451-B1 LIPOXYGENASE INHIBITORY COMPOUNDS Bristol-Myers Squibb Company (US) 1992-04-01 EP disclosed
US-4861798-A Lipoxygenase inhibitory compounds BRISTOL-MYERS COMPANY (US) 1989-08-29 US disclosed
EP-0273451-A2 Lipoxygenase inhibitory compounds Bristol-Myers Squibb Company (US) 1988-07-06 EP disclosed
US-3992396-A TRANQUILIZERS, HYPNOTICS SANDOZ, INC. (US) 1976-11-16 US disclosed